Nuvectis

Total Funding 

$15,3M

Nuvectis Pharma is a bio-pharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.

Nuvectis is led by a management team comprised of industry veterans with broad and extensive drug development experience, and a proven track record of clinical and regulatory success. By leveraging our core competencies of target selection, drug profiling, and clinical and regulatory execution we are building our pipeline of product candidates for development in various oncology indications.

Number of employees

5 - 10

Headquarters

New York, New York, US